Using clinic incentives to improve doctor conversations and care for kids ages 9–12
IMPACT Project 2 – The impact of clinic-level financial incentives tied to quality target metrics on clinical communication and health care use
This project tries to see if paying clinics for meeting quality goals helps doctors give clearer cancer-prevention recommendations to children ages 9–12.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11184368 on NIH RePORTER |
What this research studies
If your child goes to a participating primary care clinic, the clinic will be part of a randomized program where some clinics receive financial rewards tied to quality measures while others do not. Providers at all clinics will receive Announcement Approach Training (AAT) to learn how to give strong, brief recommendations for cancer-preventing services, and clinics getting incentives will also receive feedback reports tracking their performance. Researchers will survey providers nationwide, refine the feedback reports, and track whether clearer communication leads to more patients receiving recommended prevention services for ages 9–12.
Who could benefit from this research
Good fit: Children ages 9–12 who receive care at participating primary-care clinics (and their parents) are the people most likely to be affected and eligible.
Not a fit: Adults, children outside the 9–12 age range, and patients who do not go to participating clinics would not directly benefit from this project.
Why it matters
Potential benefit: If successful, this could lead to clearer doctor recommendations and higher use of cancer-prevention services for children ages 9–12.
How similar studies have performed: Prior work by this team showed AAT improves provider communication and care use, but using clinic-level financial incentives for this goal is a newer idea that has not been fully tested.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Trogdon, Justin — Univ of North Carolina Chapel Hill
- Study coordinator: Trogdon, Justin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.